Clorgyline-isopropylresorcinol conjugates as dual MAO-A/HSP90 inhibitors for glioblastoma
July 4, 2023
Novel therapeutic strategies are urgently needed to treat glioblastoma, the most aggressive type of primary brain tumor frequently associated with poor survival.
